Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enhabit, Inc.

7.68
-0.0200-0.26%
Post-market: 7.680.00000.00%18:55 EDT
Volume:243.22K
Turnover:1.87M
Market Cap:387.69M
PE:-2.47
High:7.75
Open:7.66
Low:7.55
Close:7.70
Loading ...

PE Firms May Appeal Profit-Split Court Win By Encompass Health, Enhabit

Dow Jones
·
06 Dec 2024

Enhabit, Inc. Secures Multi-Year Deal with UnitedHealthcare

TIPRANKS
·
05 Dec 2024

Encompass Health, Enhabit Entitled to Profits with Court Win Against Former Officers

Dow Jones
·
04 Dec 2024

Encompass Health, Enhabit Win Breach of Fiduciary Duty Lawsuit

MT Newswires Live
·
04 Dec 2024

BRIEF-Encompass Health And Enhabit Won Lawsuit Related To Breaches Of Fiduciary Duty By April Anthony, Luke James, Chris Walker

Reuters
·
04 Dec 2024

Enhabit awarded damages in lawsuit against former officers, private equity firms

TIPRANKS
·
04 Dec 2024

Encompass Health- on Monday, Co, Enhabit Won Lawsuit Related to Breaches of Fiduciary Duty by April Anthony, Luke James, Chris Walker

THOMSON REUTERS
·
04 Dec 2024

Enhabit, Inc.: Operational Stability Amid Growth Challenges Leads to Hold Rating

TIPRANKS
·
21 Nov 2024

Enhabit Announces Participation in Upcoming BofA Home Care Conference

Business Wire
·
20 Nov 2024

Enhabit Price Target Cut to $8.00/Share From $8.50 by Leerink Partners

Dow Jones
·
19 Nov 2024

U.S. RESEARCH ROUNDUP- Equifax, Microstrategy, Netflix

Reuters
·
19 Nov 2024

Enhabit Inc : Jefferies Cuts Target Price to $8.25 From $8.75

THOMSON REUTERS
·
19 Nov 2024

Jeffrey Bolton Bought 13% More Shares In Enhabit

Simply Wall St.
·
15 Nov 2024

Enhabit, Inc. Faces Mixed Financial Outlook Amid Growth Potential and Operational Challenges

TIPRANKS
·
11 Nov 2024

Enhabit (EHAB) Faces Challenges Post-Spinoff but Remains Attractive

Insider Monkey
·
08 Nov 2024

Enhabit Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.
·
08 Nov 2024

Enhabit, Inc.: Mixed Q3 Results and Lowered 2024 Guidance Justify Hold Rating

TIPRANKS
·
08 Nov 2024

Analysts Offer Insights on Healthcare Companies: Aclaris Therapeutics (ACRS), McKesson (MCK) and Enhabit, Inc (EHAB)

TIPRANKS
·
08 Nov 2024

Enhabit Inc (EHAB) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...

GuruFocus.com
·
08 Nov 2024

Q3 2024 Enhabit Inc Earnings Call

Thomson Reuters StreetEvents
·
08 Nov 2024